Financial Services
Aimei Health Technology Co., Ltd(AFJKR)
Live Price
Offline$0.24
+0.00% today
1Y Change
+0.00%
Window
Jun 30, 2025 → Jun 17, 2026
- Market Cap
- $270.00M
- Revenue Growth
- 0.0%
- EPS Growth
- -39.3%
- Dividend Yield
- 0.0%
Coverage: 167 bars · Jun 30, 2025 → Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Aimei Health Technology Co., Ltd (AFJKR) is a Financial Services stock with a market cap of $270.00M and listed on NASDAQ. The stock last traded around $0.24 and up 0.0% across the available one-year price window (Jun 30, 2025 → Jun 17, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of -39.3%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS -39.3%, free cash flow +15.9% with operating margin 0.0% and ROIC -9.6%. Valuation already assumes a fairly strong business story at P/E 166.1. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines AFJKR price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Financial Services peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
0.0% vs +3.4% peer median
Operating Margin
Below sector median
0.0% vs +4.7% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
The operating picture looks softer than before
Revenue is at 0.0% and EPS is at -39.3%, with operating margin around 0.0%.
Benchmark Edge
AFJKR vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
AFJKR
—
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
AFJKR Max Drawdown
-45.45%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for AFJKR and SPY.
Company Overview
Aimei Health Technology Co., Ltd
NASDAQ Global Market
Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.
- Leadership
- Junheng Xie
- IPO Date
- Dec 1, 2023
- Employees
- 2
- Street Address
- 10 East 53rd Street
- Mailing
- New York City, NY, 10022
- Region
- New York City, NY, US
- Reporting Currency
- USD
- Investor Line
- 212 845 9945
- Last Updated
- May 6, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 166.1
- EV/EBITDA
- —
- Price/Sales
- —
- Price/Book
- —
Growth
- Revenue
- 0.0%
- EPS
- -39.3%
- Free Cash Flow
- +15.9%
Profitability
- Gross Margin
- 0.0%
- Operating Margin
- 0.0%
- Net Margin
- 0.0%
- ROE
- 3.5%
- ROIC
- -9.6%
Balance Sheet
- Debt/Equity
- —
- Current Ratio
- 0.00
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.